Back to School: How biopharma can reboot drug development. Access exclusive analysis here
NOVC suspended a Phase II trial of Asentar plus gemcitabine with or without Tarceva in 132 patients after
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury